Previous studies have demonstrated the anti-inflammatory role of PGRN in CNS diseases, such as neurodegenerative diseases and ischemic stroke [19, 43], and that deficiency of PGRN resulted in exaggerated inflammation and BBB disruption [13]. This evidence concerns the gene GRN and ischemic stroke.